An experimental model of contact dermatitis: Evaluation of the oxidative profile of wistar rats treated with free and nanoencapsulated clobetasol

Redox Report

Volumn 17, Issue 5, 2012, Pages 206-213

  Jaques, Jeandre Augusto dos Santos ^a   Rezer, João Felipe Peres ^a   Ruchel, Jader Betsch ^a   Souza, Viviane do Carmo Gonçalves ^a   Pinheiro, Kelly de Vargas ^a   Schlemmer, Karine Bizzi ^a   Schlemmer, Josiane Bizzi ^a   Bertoldo, Tatiana Montagner Dalcin ^a   Martins, Nara Maria Beck ^a   Bertoncheli, Cláudia de Mello ^a   Fontana, Márcia Camponogara ^a,b   Beck, Ruy Carlos Ruver ^b   Leal, Daniela Bitencourt Rosa ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Clobetasol; Contact dermatitis; Nanostructured; Oxidative stress

Indexed keywords

CATALASE; CLOBETASOL PROPIONATE; NANOPARTICLE; NICKEL SULFATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FEMALE; HYDROGEL; LIVER; LIVER HOMOGENATE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN SENSITIZATION; WISTAR RAT;

ANIMALS; CATALASE; CLOBETASOL; DERMATITIS, CONTACT; DRUG CARRIERS; FEMALE; LIPID PEROXIDATION; NANOSTRUCTURES; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84867681272     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000212Y.0000000024     Document Type: Article

References (51)

1. Fyhrquist-Vanni N, Alenius H, Lauerma A. Contact dermatitis. Dermatol Clin 2007;25(4):613-23, x.
2. Slodownik D, Lee A, Nixon R. Irritant contact dermatitis: a review. Australas J Dermatol 2008;49(1):1-9; quiz 10-1.
3. Saint-Mezard P, Rosieres A, Krasteva M, Berard F, Dubois B, Kaiserlian D, et al. Allergic contact dermatitis. Eur J Dermatol 2004;14(5):284-95.
4. Lepoittevin JP, Leblond I. Hapten-peptide T cell interactions: molecular basis for the recognition of haptens by T lymphocytes. Eur J Dermatol 1997;7(3):151-4.
5. Asano Y, Makino T, Norisugi O, Shimizu T. Occupational cobalt induced systemic contact dermatitis. Eur J Dermatol 2009;19(2):166-7.
6. Nicolas JF, Testud F, Vocanson M. Sensibilisation versus tolerance dans l'eczema de contact. Ann Dermatol Venereol 2008;135:733-6.
7. Saloga J, Knop J, Kolde G. Ultrastructural cytochemical visualization of chromium in the skin of sensitized guinea pigs. Arch Dermatol Res 1988;280(4):214-9.
8. Krasteva M, Kehren J, Ducluzeau MT, Sayag M, Cacciapuoti M, Akiba H, et al. Contact dermatitis I. Pathophysiology of contact sensitivity. Eur J Dermatol 1999;9(1):65-77.
9. Wiedersberg S, Leopold CS, Guy RH. Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopharm 2008;68(3):453-66.
10. Gagliardi L, Orsi D, Giudice M, Gatta F, Porra R, Chimenti P, et al. Development of a tandem thin-layer chromatography-highperformance liquid chromatography method for the identification and determination of corticosteroids in cosmetic products. Analytica Chimica Acta 2002;457(2):187-98.
11. Reepmeyer J, Revelee L, Vidavsky I. Detection of clobetasol propionate as an undeclared steroid in zinc pyrithione formulations by high-performance liquid chromatography with rapid-scanning ultraviolet spectroscopy and mass spectrometry. J Chromatogr A 1998;828(1-2):239-46.
12. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006;54(1): 1-15; quiz 6-8.
13. Fang JY, Shen KL, Huang YB, Wu PC, Tsai YH. Evaluation of topical application of clobetasol 17-propionate from various cream bases. Drug Dev Ind Pharm 1999;25(1):7-14.
14. Honeywell-Nguyen P, Bouwstra J. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today, Technol 2005;2(1): 67-74.
15. Ramon E, Alonso C, Coderch L, de la Maza A, Lopez O, Parra JL, et al. Liposomes as alternative vehicles for sun filter formulations. Drug Deliv 2005;12(2):83-8.
16. Tursilli R, Piel G, Delattre L, Scalia S. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle. Eur J Pharm Biopharm 2007;66(3):483-7.
17. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002; 54(Suppl. 1):S131-55.
18. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004;21(10):1818-25.
19. Wissing SA, Muller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release 2002;81(3):225-33.
20. Alvarez-Roman R, Barre G, Guy RH, Fessi H. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur J Pharm Biopharm 2001;52(2):191-5.
21. Perugini P, Simeoni S, Scalia S, Genta I, Modena T, Conti B, et al. Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p-methoxycinnamate. Int J Pharm 2002;246(1-2):37-45.
22. Vettor M, Perugini P, Scalia S, Conti B, Genta I, Modena T, et al. Poly(D, L-lactide) nanoencapsulation to reduce photoinactivation of a sunscreen agent. Int J Cosmet Sci 2008;30(3): 219-27.
23. Ourique AF, Melero A, Silva CD, Schaefer UF, Pohlmann AR, Guterres SS, et al. Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. Eur J Pharm Biopharm 2011;79(1):95-101.
24. Alves MP, Scarrone AL, Santos M, Pohlmann AR, Guterres SS. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 2007; 341(1-2):215-20.
25. Marchiori ML, Lubini G, Dalla Nora G, Friedrich RB, Fontana MC, Ourique AF, et al. Hydrogel containing dexamethasoneloaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study. Drug Dev Ind Pharm 2010;36(8):962-71.
26. Fontana MC, Coradini K, Guterres SS, Pohlmann AR, Beck RC. Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system. J Biomed Nanotechnol 2009; 5(3):254-63.
27. Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 2008;363(1-2):132-8.
28. De Jalon EG, Blanco-Prieto MJ, Ygartua P, Santoyo S. PLGA microparticles: possible vehicles for topical drug delivery. Int J Pharm 2001;226(1-2):181-4.
29. Jenning V, Gysler A, Schafer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000;49(3):211-8.
30. Luengo J, Weiss B, Schneider M, Ehlers A, Stracke F, Konig K, et al. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol 2006;19(4):190-7.
31. Siqueira NM, Contri RV, Paese K, Beck RC, Pohlmann AR, Guterres SS. Innovative sunscreen formulation based on benzophenone-3-loaded chitosan-coated polymeric nanocapsules. Skin Pharmacol Physiol 2011;24(3):166-74.
32. Fontana MC, Rezer JF, Coradini K, Leal DB, Beck RC. Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate. Eur J Pharm Biopharm 2011;79(2):241-249.
33. Fessi H, Devissaguet J, Puisieux F. Procédé de préparation de systèmes colloïdaux dispersibles d'une substance sous forme de nanocapsules. European Patent No 0274961-A1. 1988.
34. Tolosa EMC, Rodrigues CJ. Manual de técnicas para histologia normal e patológica. 2nd ed. São Paulo: Manole; 2003.
35. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351-8.
36. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464-78.
37. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82(1):70-7.
38. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
39. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
40. Rao G, Murthy R. Evaluation of liposomal clobetasol propionate topical formulation for intra-dermal delivery. Indian J Pharm Sci 2000;62(6):459-62.
41. Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 2007;66(2):159-64.
42. ANVISA. Bula do profissional da saúde: bulário eletrônico da ANVISA. 2011.
43. GrottoD, Valentini J, Boeira S, PanizC, Maria L, Vicentini J, et al. Avaliação da estabilidade domarcador plasmático do estresse oxidativo-malondialdeído. Química Nova 2008;31(2):275-9.
44. Jentzsch AM, Bachmann H, Furst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996;20(2):251-6.
45. Blauvelt A, Hwang ST, Udey MC. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol 2003;111(2 Suppl.):S560-70.
46. Watanabe H, Unger M, Tuvel B, Wang B, Sauder DN. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J Interferon Cytokine Res 2002; 22(4):407-12.
47. Cavani A, Albanesi C, Traidl C, Sebastiani S, Girolomoni G. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 2001;22(3):118-20.
48. Fehr BS, Takashima A, Matsue H, Gerometta JS, Bergstresser PR, Cruz PD, Jr. Contact sensitization induces proliferation of heterogeneous populations of hapten-specific T cells. Exp Dermatol 1994;3(4):189-97.
49. Fuchs J, Freisleben HJ, Packer L. Antioxidants in the skin. Boca Raton, Florida: CRC Press; 1992.
50. Picardo M, Zompetta C, Grandinetti M, Ameglio F, Santucci B, Faggioni A, et al. Paraphenylenediamine, a contact allergen, induces oxidative stress and ICAM-1 expression in human keratinocytes. Br J Dermatol 1996;134:681-5.
51. Sharkey P, Eddy DJ, Burrows D, McCaigue MD, Bell AL. A possible role for superoxide production in the pathogenesis of contact dermatitis. acta dermato-venereologica. 1990;71: 156-9.